Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 3, Pages 277
Publisher
MDPI AG
Online
2019-02-27
DOI
10.3390/cancers11030277
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia
- (2018) Tina Nuebling et al. Cancer Immunology Research
- Impacts of Cancer on Platelet Production, Activation and Education and Mechanisms of Cancer-Associated Thrombosis
- (2018) Léa Plantureux et al. Cancers
- Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells
- (2017) Stefanie Maurer et al. OncoImmunology
- Exploitation of natural killer cells for the treatment of acute leukemia
- (2016) Rupert Handgretinger et al. BLOOD
- Abstract S2-02: The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trial
- (2016) M Gnant et al. CANCER RESEARCH
- An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia
- (2016) S P Koerner et al. LEUKEMIA
- NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy
- (2015) Garnet Suck et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis
- (2015) J Wild et al. LEUKEMIA
- Platelet-derived RANK ligand enhances CCL17 secretion from dendritic cells mediated by thymic stromal lymphopoietin
- (2014) Takahisa Nakanishi et al. PLATELETS
- CD154 Is Released from T-cells by a Disintegrin and Metalloproteinase Domain-containing Protein 10 (ADAM10) and ADAM17 in a CD40 Protein-dependent Manner
- (2013) Daniel Yacoub et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A “vicious cycle” of NK-cell immune evasion in acute myeloid leukemia mediated by RANKL?
- (2013) Benjamin Joachim Schmiedel et al. OncoImmunology
- Receptor Activator for NF- B Ligand in Acute Myeloid Leukemia: Expression, Function, and Modulation of NK Cell Immunosurveillance
- (2012) B. J. Schmiedel et al. JOURNAL OF IMMUNOLOGY
- GITR Ligand Provided by Thrombopoietic Cells Inhibits NK Cell Antitumor Activity
- (2012) T. Placke et al. JOURNAL OF IMMUNOLOGY
- RANKL Expression Specifically Observed in Vivo Promotes Epithelial Mesenchymal Transition and Tumor Progression
- (2011) Tamaki Yamada et al. AMERICAN JOURNAL OF PATHOLOGY
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
- (2011) Myriam Labelle et al. CANCER CELL
- Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells
- (2011) T. Placke et al. CANCER RESEARCH
- Modulation of Natural Killer Cell Anti-Tumor Reactivity by Platelets
- (2011) Theresa Placke et al. Journal of Innate Immunity
- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling
- (2011) Wei Tan et al. NATURE
- Cutting Edge: NKp80 Uses an Atypical Hemi-ITAM To Trigger NK Cytotoxicity
- (2010) K. M. Dennehy et al. JOURNAL OF IMMUNOLOGY
- CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells
- (2009) T. Baessler et al. BLOOD
- Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Protein Ligand Subverts Immunosurveillance of Acute Myeloid Leukemia in Humans
- (2009) T. Baessler et al. CANCER RESEARCH
- Platelet-Derived Transforming Growth Factor- Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity
- (2009) H.-G. Kopp et al. CANCER RESEARCH
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucocorticoid-induced Tumor Necrosis Factor Receptor Negatively Regulates Activation of Human Primary Natural Killer (NK) Cells by Blocking Proliferative Signals and Increasing NK Cell Apoptosis
- (2008) Baoying Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RANK ligand as a therapeutic target for bone metastases and multiple myeloma
- (2007) G. David Roodman et al. CANCER TREATMENT REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now